Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39,252	24,243	18,858	24,266	14,979	11,060
Market Cap Growth	57.21%	28.56%	-22.29%	62.00%	35.43%	14.08%
Enterprise Value	39,288	24,200	19,060	24,537	14,677	10,722
Last Close Price	297.41	190.55	151.59	191.34	119.22	99.03
PS Ratio	16.44	13.50	13.14	28.18	24.02	30.64
PB Ratio	225.58	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	225.58	452.40	-	-	34.48	14.86
P/FCF Ratio	238.35	-	572.67	-	-	-
P/OCF Ratio	198.45	-	230.62	-	-	-
EV/Sales Ratio	16.41	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	238.57	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.08%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.42%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.